Upgrade to SI Premium - Free Trial

Leerink Swann Starts Veracyte, Inc (VCYT) at Outperform, Sees 50% Upside

November 26, 2013 7:36 AM
Leerink Swann initiates coverage on Veracyte, Inc (NASDAQ: VCYT) with a Outperform rating and $17 price target, representing 50% upside ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Hot New Coverage New Coverage

Next Articles